DVM
TMO icon

Dreman Value Management’s Thermo Fisher Scientific TMO Stock Holding History

Dreman Value Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-37
Closed -$6K – 442
2017
Q1 		$6K Sell
37
-8,825
-100% -$1.35M ﹤0.01% 238
2016
Q4 		$1.25M Sell
8,862
-481
-5% -$70.9K 0.7% 33
2016
Q3 		$1.49M Sell
9,343
-468
-5% -$72.1K 0.9% 33
2016
Q2 		$1.45M Sell
9,811
-326
-3% -$48.1K 0.9% 39
2016
Q1 		$1.44M Buy
+10,137
New +$1.36M 0.16% 145
2015
Q4 		– Sell
-14,000
Closed -$1.71M – 396
2015
Q3 		$1.71M Sell
14,000
-632
-4% -$82.3K 0.17% 147
2015
Q2 		$1.9M Sell
14,632
-650
-4% -$84.7K 0.16% 188
2015
Q1 		$2.05M Sell
15,282
-702
-4% -$90.5K 0.18% 175
2014
Q4 		$2M Sell
15,984
-229
-1% -$27.8K 0.16% 196
2014
Q3 		$1.97M Sell
16,213
-207
-1% -$25.2K 0.16% 199
2014
Q2 		$1.94M Sell
16,420
-7,068
-30% -$832K 0.15% 204
2014
Q1 		$2.82M Buy
23,488
+9,148
+64% +$1.09M 0.22% 179
2013
Q4 		$2.72M Sell
14,340
-14,559
-50% -$1.45M 0.21% 189
2013
Q3 		$2.66M Buy
+28,899
New +$2.61M 0.24% 165

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dreman Value Management's TMO Position: Q2 2017 in Review

Dreman Value Management sold out of Thermo Fisher Scientific (TMO) in Q2 2017, closing a stake of 37 shares — an estimated $6K sold.

Dreman Value Management first reported a position in TMO in Q3 2013 and held it in 14 quarters. The position peaked at $2.82M in Q1 2014. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

  • Dreman Value Management reported no remaining Thermo Fisher Scientific position as of Q2 2017 after selling out during the quarter.
  • Dreman Value Management sold 37 Thermo Fisher Scientific shares in Q2 2017, an estimated $6K.
  • Dreman Value Management first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 14 quarters.
  • Dreman Value Management's Thermo Fisher Scientific position peaked at $2.82M in Q1 2014.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on Dreman Value Management's 13F filing for Q2 2017, filed 16 Aug 2017.